This correction addresses previous findings on the relationship between plasma phosphorylated tau217 and cognitive impairment as well as brain alterations in Alzheimer's disease.
Correction to previously published data regarding plasma phosphorylated tau217 measurements.
Review of cognitive assessments and brain imaging related to Alzheimer's disease.
Clarified associations of elevated plasma phosphorylated tau217 with increased cognitive impairment in Alzheimer's disease.
Revised microstructural alteration data in relation to cognitive outcomes.
Abstract
This corrects the article DOI: 10.1002/dad2.70333..